Vision-Sciences, Inc. Announces Participation in Upcoming Financial Conference

Chief Executive Officer and Chief Financial Officer will present at the conference.

Orangeburg, NY (PRWEB) November 25, 2007 -- Vision-Sciences, Inc., (Nasdaq:VSCI)., today announced that it will participate in the Wall Street Analyst Forum Investor Conference on November 28, 2007, at The Princeton Club on 43rd Street between 5th & 6th (4th Floor) in NYC.

Ron Hadani, Chief Executive Officer and Yoav M. Cohen, Chief Financial Officer will present at the conference at 8:30 a.m. Eastern Standard Time. To register and view the conference schedule, please visit www.analyst-conference.com

About Vision-Sciences, Inc.

Vision-Sciences, Inc. (Nasdaq:VSCI) develops, manufactures and markets unique flexible endoscopic products for the urology, gastroenterology and the ENT markets, utilizing the proprietary sterile disposable EndoSheath® Technology. This technology provides quick and efficient equipment turnover, and ensures the patient a contaminant-free endoscope insertion. For more information, please visit www.visionsciences.com

###


Contact Information
Yoav M. Cohen
Vision-Sciences, Inc.
http://www.visionsciences.com
845-365-0600

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy